CARDIOMYO, the European consortium project led by ZeClinics and its partners Taros Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the prestigious EUREKA- EUROSTARS innovation program.
Discovering the world of chemistry
Taros, an independent and privately owned contract research organization (CRO), has been supporting pharmaceutical, biotech and chemical companies with chemistry services since 1999.
Home » Home
Latest News
Read more
The French Medicinal Chemistry Society is pleased to invite to the 56th edition of the International Conference on Medicinal Chemistry.
At BIO Digital more than 5,000 participants from 55 countries come together for a One-on-One Partnering, education and networking with professionals from life science and pharmaceutical industry…
The Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates…
Discovery Chemistry services to materialize your ideas
At Taros we regularly perform contract research with an emphasis on the design and synthesis of novel building blocks, intermediates and final compounds for several applications. We pride ourselves on a 20 year track record of success in supporting diverse industries with their chemistry and innovation challenges. Our scientists specialize in organic and organometallic synthesis including polymers, from lab scale to pilot quantities. Taros operates a customer-centric and flexible business model providing our diverse clients with customized innovative discovery chemistry services:
We provide long-term added value to our diverse customers through discovery chemistry services and contract research
Our contract research focuses on holistic and cost-effective solutions of the highest quality for the global marketplace. We are inspired to provide exceptional added value to our customers’ R&D processes by anticipating hurdles foreseeing cost and lead time reductions. Thereby we facilitate competitive and “early-to-market” advantages. With our state-of-the-art lab facilities and our scientists (of which 65% hold a Ph.D. in Chemistry), we are committed to serve the diverse needs of our customers with discovery chemistry services in drug discovery, custom synthesis and specialty or performance chemicals. More than 13,000 synthesis, research and process chemistry projects have been delivered successfully to our ever-growing global customer base.
